RID System (ACP) Test
510(k) K781408
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK781408 | Date21 Aug 1978 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DEM
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5130
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The RID System (ACP) Test is a radial immunodiffusion (RID) assay designed for the quantitative measurement of alpha-1 antitrypsin (ACP) antigen levels in serum or plasma. It employs a gel-based immunodiffusion technique to detect and quantify specific proteins, aiding in the diagnosis and monitoring of conditions related to alpha-1 antitrypsin deficiency. The test utilizes antiserum and control reagents to facilitate precise immunochemical reactions, ensuring accurate results for clinical evaluation.
This device is supplied as a kit containing all necessary reagents for performing the test, including antigen, antiserum, and controls. It is intended for single-use in laboratory settings and requires no special storage conditions beyond refrigeration to maintain stability. The RID System (ACP) Test is classified under FDA device classification DEM (Diagnostic, Electrophoresis, Miscellaneous) and holds a Traditional 510(k) clearance with a decision date of August 21, 1978. Compliance with regulatory standards ensures its suitability for immunology applications in clinical diagnostics.
Other devices from Icl Scientific
Questions
AI-generated answers, 1 Oct 2026
What is the RID System (ACP) Test used for?
The RID System (ACP) Test is designed for the quantitative measurement of alpha-1 antitrypsin (ACP) antigen levels in serum or plasma. It employs a radial immunodiffusion technique to detect and quantify specific proteins, aiding in diagnosing and monitoring alpha-1 antitrypsin deficiency and related conditions. This method ensures precise immunochemical reactions for reliable clinical results.
How is the RID System (ACP) Test supplied, and what does the kit include?
The RID System (ACP) Test is supplied as a complete kit containing all necessary reagents for performing the assay. This includes antigen, antiserum, and control reagents, which are essential for conducting the radial immunodiffusion test in a laboratory setting. The kit is intended for single-use only.
What storage conditions are required for the RID System (ACP) Test?
The RID System (ACP) Test does not require special storage conditions beyond standard refrigeration to maintain stability. Proper refrigeration ensures the reagents remain effective for accurate testing, and it is important to follow storage guidelines to preserve the integrity of the antiserum and controls included in the kit.
Is the RID System (ACP) Test intended for reuse, or is it single-use?
The RID System (ACP) Test is explicitly designed for single-use only. Each kit contains all necessary reagents for one test, ensuring consistency and reliability in results. Reusing components could compromise accuracy and introduce contamination risks, which is why it is not recommended.
What regulatory pathway does the RID System (ACP) Test follow?
The RID System (ACP) Test holds a Traditional 510(k) clearance from the FDA, with a decision date of August 21, 1978. It is classified under the product code DEM (Diagnostic, Electrophoresis, Miscellaneous) and falls under the Immunology advisory committee (IM). This clearance confirms its compliance with regulatory standards for immunology applications in clinical diagnostics.